This HTML5 document contains 188 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n18http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0158605/
n3http://linked.opendata.cz/ontology/sukl/
n7http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0158605/core-reimbursement/
n8http://linked.opendata.cz/resource/sukl/specialization-restriction/
n12http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0158605/price/
skoshttp://www.w3.org/2004/02/skos/core#
n5http://linked.opendata.cz/resource/sukl/indgroup/
n16http://linked.opendata.cz/resource/sukl/packing/
n10http://linked.opendata.cz/resource/sukl/company/
n13http://linked.opendata.cz/resource/sukl/active-ingredient/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n17http://linked.opendata.cz/resource/sukl/registration-state/
xsdhhttp://www.w3.org/2001/XMLSchema#
n20http://www.sukl.cz/modules/medication/
n6http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0158605/price-of-originator/
n11http://linked.opendata.cz/resource/sukl/df/
n15http://linked.opendata.cz/resource/atc/
n9http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0158605/reimbursement/

Statements

Subject Item
n2:0158605
rdf:type
n3:MedicinalProductPackaging
dcterms:title
IBANDRONIC ACID ACTAVIS 150 MG
skos:notation
0158605
n3:hasATCCode
n15:M05BA06
n3:hasActiveIngredient
n13:NATRII-IBANDRONAS-MONOHYDRICUS
n3:hasDefinedDailyDose
n4:ddd
n3:hasDosageForm
n11:TBL-FLM-POR
n3:hasPackagingSize
3 I
n3:hasPacking
n16:BLI
n3:hasRegistrationHolder
n10:ACKIS
n3:hasRegistrationState
n17:R
n3:hasRouteOfAdministration
n18:POR
n3:hasStrength
150MG
n3:hasIndicationGroup
n5:87
n3:hasSpecializationRestriction
n8:GYN n8:END n8:INT n8:ORT n8:REV
n3:containsDefinedDailyDoses
90.0
n3:hasRegistrationCode
87/ 054/11-C
n3:hasTitleSupplement
POR TBL FLM 3X150MG I
n3:containsUsualTherapeuticalDailyDoses
90
n3:hasCoreReimbursementSpecification
n7:2013-05-01 n7:2013-06-01 n7:2013-03-01 n7:2013-04-01 n7:2013-01-05 n7:2013-02-01 n7:2013-01-01 n7:2013-12-01 n7:2014-01-01 n7:2013-10-01 n7:2013-11-01 n7:2013-08-03 n7:2013-09-01 n7:2013-07-01 n7:2013-08-01 n7:2014-07-01 n7:2014-07-03 n7:2014-06-01 n7:2014-06-13 n7:2014-04-01 n7:2014-05-01 n7:2014-02-01 n7:2014-03-01 n7:2014-12-01 n7:2015-01-01 n7:2014-11-01 n7:2014-11-19 n7:2014-10-01 n7:2014-10-02 n7:2014-08-01 n7:2014-09-01 n7:2015-06-01 n7:2015-07-01 n7:2015-04-02 n7:2015-05-01 n7:2015-03-01 n7:2015-04-01 n7:2015-01-13 n7:2015-02-01 n7:2015-07-02
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n6:2014-10-01 n6:2014-10-02 n6:2014-08-01 n6:2014-09-01 n6:2014-12-01 n6:2015-01-01 n6:2014-11-01 n6:2014-11-19 n6:2014-04-01 n6:2014-05-01 n6:2014-02-01 n6:2014-03-01 n6:2014-07-01 n6:2014-07-03 n6:2014-06-01 n6:2014-06-13 n6:2013-08-03 n6:2013-09-01 n6:2013-07-01 n6:2013-08-01 n6:2013-12-01 n6:2014-01-01 n6:2013-10-01 n6:2013-11-01 n6:2013-01-05 n6:2013-02-01 n6:2013-01-01 n6:2013-05-01 n6:2013-06-01 n6:2013-03-01 n6:2013-04-01 n6:2015-07-02 n6:2015-03-01 n6:2015-04-01 n6:2015-01-13 n6:2015-02-01 n6:2015-06-01 n6:2015-07-01 n6:2015-04-02 n6:2015-05-01
n3:hasPriceSpecification
n12:2015-07-02 n12:2015-04-02 n12:2015-05-01 n12:2015-06-01 n12:2015-07-01 n12:2015-01-13 n12:2015-02-01 n12:2015-03-01 n12:2015-04-01 n12:2014-11-01 n12:2014-11-19 n12:2014-12-01 n12:2015-01-01 n12:2014-08-01 n12:2014-09-01 n12:2014-10-01 n12:2014-10-02 n12:2014-06-01 n12:2014-06-13 n12:2014-07-01 n12:2014-07-03 n12:2014-02-01 n12:2014-03-01 n12:2014-04-01 n12:2014-05-01 n12:2013-10-01 n12:2013-11-01 n12:2013-12-01 n12:2014-01-01 n12:2013-07-01 n12:2013-08-01 n12:2013-08-03 n12:2013-09-01 n12:2013-03-01 n12:2013-04-01 n12:2013-05-01 n12:2013-06-01 n12:2013-01-01 n12:2013-01-05 n12:2013-02-01
n3:hasReimbursementSpecification
n9:2015-07-02 n9:2015-06-01 n9:2015-07-01 n9:2015-04-02 n9:2015-05-01 n9:2015-03-01 n9:2015-04-01 n9:2015-01-13 n9:2015-02-01 n9:2014-12-01 n9:2015-01-01 n9:2014-11-01 n9:2014-11-19 n9:2014-10-01 n9:2014-10-02 n9:2014-08-01 n9:2014-09-01 n9:2014-07-01 n9:2014-07-03 n9:2014-06-01 n9:2014-06-13 n9:2014-04-01 n9:2014-05-01 n9:2014-02-01 n9:2014-03-01 n9:2013-12-01 n9:2014-01-01 n9:2013-10-01 n9:2013-11-01 n9:2013-08-03 n9:2013-09-01 n9:2013-07-01 n9:2013-08-01 n9:2013-05-01 n9:2013-06-01 n9:2013-03-01 n9:2013-04-01 n9:2013-01-05 n9:2013-02-01 n9:2013-01-01
n3:hasResumedMarketingDate
2012-07-23+02:00
n3:hasUsualTherapeuticalDailyDose
n4:utdd
n3:spcFile
http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC43227.pdf%26type%3Dspc%26as%3Dibandronic-acid-actavis-150-mg-spc
n3:spcUri
n20:download.php?file=SPC43227.pdf&type=spc&as=ibandronic-acid-actavis-150-mg-spc